AMT, Consortium To Develop Sanfilippo B Gene Therapy
Amsterdam Molecular Therapeutics to supply cGMP manufacturing to consortium led by Institut Pasteur for clinical development of therapy for rare genetic disorder in children (pictured: AMT CEO Jorn Aldag).
Read More